These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 10333319)

  • 1. Bisquinoline antimalarials: their role in malaria chemotherapy.
    Raynes K
    Int J Parasitol; 1999 Mar; 29(3):367-79. PubMed ID: 10333319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline antimalarials: mechanisms of action and resistance.
    Foley M; Tilley L
    Int J Parasitol; 1997 Feb; 27(2):231-40. PubMed ID: 9088993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents.
    Foley M; Tilley L
    Pharmacol Ther; 1998 Jul; 79(1):55-87. PubMed ID: 9719345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel bisquinoline antimalarials. Synthesis, antimalarial activity, and inhibition of haem polymerisation.
    Raynes K; Foley M; Tilley L; Deady LW
    Biochem Pharmacol; 1996 Aug; 52(4):551-9. PubMed ID: 8759027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
    Gorka AP; de Dios A; Roepe PD
    J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of heme in the antimalarial action of chloroquine.
    Fitch CD
    Trans Am Clin Climatol Assoc; 1998; 109():97-105; discussion 105-6. PubMed ID: 9601131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs.
    Fitch CD
    Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.
    Loria P; Miller S; Foley M; Tilley L
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):363-70. PubMed ID: 10191268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines.
    C S Pinheiro L; M Feitosa L; O Gandi M; F Silveira F; Boechat N
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31766184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
    van Schalkwyk DA; Egan TJ
    Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.
    Vennerstrom JL; Ellis WY; Ager AL; Andersen SL; Gerena L; Milhous WK
    J Med Chem; 1992 May; 35(11):2129-34. PubMed ID: 1597862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Antimalarial Activity at a Putative Bisquinoline Receptor In Vivo Using Fluorinated Bisquinolines.
    Fielding AJ; Lukinović V; Evans PG; Alizadeh-Shekalgourabi S; Bisby RH; Drew MGB; Male V; Del Casino A; Dunn JF; Randle LE; Dempster NM; Nahar L; Sarker SD; Cantú Reinhard FG; de Visser SP; Dascombe MJ; Ismail FMD
    Chemistry; 2017 May; 23(28):6811-6828. PubMed ID: 28261884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoline-Based Hybrid Compounds with Antimalarial Activity.
    Nqoro X; Tobeka N; Aderibigbe BA
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29257067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
    Zarchin S; Krugliak M; Ginsburg H
    Biochem Pharmacol; 1986 Jul; 35(14):2435-42. PubMed ID: 3524576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theories on malarial pigment formation and quinoline action.
    Sullivan DJ
    Int J Parasitol; 2002 Dec; 32(13):1645-53. PubMed ID: 12435449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common mechanism for blockade of heme polymerization by antimalarial quinolines.
    Sullivan DJ; Matile H; Ridley RG; Goldberg DE
    J Biol Chem; 1998 Nov; 273(47):31103-7. PubMed ID: 9813011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematin (haem) polymerization and its inhibition by quinoline antimalarials.
    Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL
    Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium: resistance to antimalarial drugs.
    Peters W
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():103-6. PubMed ID: 2264669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
    Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
    J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.